| |
◆美国指南
The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure
The JNC 7 Report
Aram V. Chobanian, MD; George L. Bakris, MD; Henry R. Black, MD; William
C. Cushman, MD; Lee A. Green, MD, MPH; Joseph L. Izzo, Jr, MD; Daniel
W. Jones, MD; Barry J. Materson, MD, MBA; Suzanne Oparil, MD; Jackson
T. Wright, Jr, MD, PhD; Edward J. Roccella, PhD, MPH; and the National
High Blood Pressure Education Program Coordinating Committee
JAMA. 2003;289:(DOI 10.1001/jama.289.19.2560).
◆摘要
ABSTRACT
"The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure"
provides a new guideline for hypertension prevention and management.
The following are the key messages: (1) In persons older than 50 years,
systolic blood pressure (BP) of more than 140 mm Hg is a much more
important cardiovascular disease (CVD) risk factor than diastolic
BP; (2) The risk of CVD, beginning at 115/75 mm Hg, doubles with each
increment of 20/10 mm Hg; individuals who are normotensive at 55 years
of age have a 90% lifetime risk for developing hypertension; (3) Individuals
with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to
89 mm Hg should be considered as prehypertensive and require health-promoting
lifestyle modifications to prevent CVD; (4) Thiazide-type diuretics
should be used in drug treatment for most patients with uncomplicated
hypertension, either alone or combined with drugs from other classes.
Certain high-risk conditions are compelling indications for the initial
use of other antihypertensive drug classes (angiotensin-converting
enzyme inhibitors, angiotensin-receptor blockers, -blockers, calcium
channel blockers); (5) Most patients with hypertension will require
2 or more antihypertensive medications to achieve goal BP (<140/90
mm Hg, or <130/80 mm Hg for patients with diabetes or chronic kidney
disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration
should be given to initiating therapy with 2 agents, 1 of which usually
should be a thiazide-type diuretic; and (7) The most effective therapy
prescribed by the most careful clinician will control hypertension
only if patients are motivated. Motivation improves when patients
have positive experiences with and trust in the clinician. Empathy
builds trust and is a potent motivator. Finally, in presenting these
guidelines, the committee recognizes that the responsible physician's
judgment remains paramount.
编辑 郑麓薇
|
|